For the year ending 2025-12-31, NHI had -$6,878K decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 140,787 |
| Depreciation and amortization | 80,944 |
| Amortization of lease incentives | 2,901 |
| Amortization of commitment fees and notes receivable discounts | 920 |
| Amortization of debt issuance costs and discounts | 3,427 |
| Payments of lease incentives | 0 |
| Share-based compensation expense | 5,576 |
| Non-cash rental income related to operations transfers upon early lease terminations | 1,375 |
| Other non-cash rental income | 0 |
| Non-cash changes in straight-line rents receivable | -7,265 |
| Non-cash interest income on mortgage and other notes receivable | 1,735 |
| Non-cash lease incentives recognized as interest and other income | 0 |
| Loan and realty (gains) losses, net | -3,447 |
| Gains on sales of real estate properties, net | 456 |
| Gains from equity method investment | 3,664 |
| Loss on early retirement of debt | 0 |
| Gains on forward equity sales agreements, net | 0 |
| Other assets, net | -57 |
| Accounts payable and other liabilities | 5,490 |
| Deferred income | 1,713 |
| Net cash provided by operating activities | 236,563 |
| Acquisitions of real estate properties | 274,068 |
| Investments in existing real estate properties and equipment | 19,966 |
| Proceeds from sales of real estate properties | 0 |
| Investments in mortgage and other notes receivable | 71,110 |
| Payments received on mortgage and other notes receivable | 92,331 |
| Distributions from equity method investment | 3,664 |
| Net cash used in investing activities | -269,149 |
| Proceeds from revolving credit facility | 694,000 |
| Repayments of revolving credit facility | 821,200 |
| Borrowings on bank term loan | 0 |
| Repayments of bank term loan and private placement notes | 200,815 |
| Proceeds from issuance of senior notes | 346,161 |
| Payments of debt issuance costs | 3,881 |
| Proceeds from issuance of common shares, net | 181,533 |
| Payments of equity issuance costs | 767 |
| Capital contributions from noncontrolling interests | 1,746 |
| Distributions paid to noncontrolling interests | 917 |
| Dividends paid to stockholders | 169,696 |
| Taxes paid related to net settlement of stock incentive awards | 456 |
| Net cash provided by (used in) financing activities | 25,708 |
| (decrease) increase in cash, cash equivalents and restricted cash | -6,878 |
| Cash, cash equivalents and restricted cash at the beginning of the year | 26,502 |
| Cash, cash equivalents and restricted cash at the end of the year | 19,624 |
NATIONAL HEALTH INVESTORS INC (NHI)
NATIONAL HEALTH INVESTORS INC (NHI)